Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton
Year: 2023
Type: article
Abstract: Senescence drives organismal aging, yet the deep characterization of senescent cells in vivo remains incomplete. Here, we apply mass cytometry by time-of-flight using carefully validated antibodies to analyze senescent cells at single-cell resolution. We use multiple criteria to identify senescent mesenchymal cells that are growth-arrested and resistant to apoptosis. These p16 + Ki67-BCL-2+ cells are highly enriched for senescence-associated secretory phenotype and DNA damage markers, are strongly associated with age, and their percentages are increased in late osteoblasts/osteocytes and CD24 high osteolineage cells. Moreover, both late osteoblasts/osteocytes and CD24 high osteolineage cells are robustly cleared by genetic and pharmacologic senolytic therapies in aged mice. Following isolation, CD24+ skeletal cells exhibit growth arrest, senescence-associated β-galactosidase positivity, and impaired osteogenesis in vitro. These studies thus provide an approach using multiplexed protein profiling to define senescent mesenchymal cells in vivo and identify specific skeletal cell populations cleared by senolytics.
Source: Nature Communications
Authors: Madison L. Doolittle, Dominik Saul, Japneet Kaur, Jennifer L. Rowsey, Stephanie J. Vos, Kevin D. Pavelko, Joshua N. Farr, David G. Monroe, Sundeep Khosla
Institutions: Mayo Clinic, BG Klinik Tübingen, University of Tübingen
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,290
Funders: U.S. Department of Health and Human Services, Mayo Clinic, American Federation for Aging Research, Glenn Foundation for Medical Research, Deutsche Forschungsgemeinschaft, Fondation pour la Recherche Médicale, National Institutes of Health, Center for Clinical and Translational Science, Mayo Clinic, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences
Awards: G1952034522, G2909676950, Zelldynamik in Pathogenese und Therapie, The Role of miR-219a-5p in Bone Metabolism, G3616143173, G5212169021, G5972303688, G614564937, G6946008088, Postdoctoral Training Program for Research on Aging, G8545843497, Mayo Clinic Center for Clinical and Translational Science (CCaTS), Midwest Murine-Tissue Mapping Center (MM-TMC), Targeting Cellular Senescence to Extend Healthspan, Defining the interactions of senescent immune cells and skeletal cells, Targeting Cellular Senescence and RAGE in Type 2 Diabetes
OpenAlex ID: W4385426207
